Carcinogenesis, Vol. 21, No. 2, 153-160,
February 2000
© 2000 Oxford University Press
Cancer Biology |
Expression of the p53 homologue p63
and 
Np63 in normal and neoplasticcells
Department of Molecular and Cellular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
A burgeoning family of p53-related genes have been described recently, including p73 and p63. Both these genes encode proteins with many similarities to p53 but also with the potential for forming a range of related species by alternative promoter usage and alternative splicing. In order to begin the characterization of p63, we generated a polyclonal serum (designated SC1) that recognizes the C-terminus of p63
. We have shown that this reagent recognizes p63 but not p53 nor p73. By western blot analysis both p63 and the N-terminal truncated form of p63 (
Np63) were found in a range of cell lines. Similar immunoblot analysis of tissues reveals considerable complexity with at least four SC1-immunoreactive isoforms being identified. In immunohistological studies SC1 immunoreactivity is widely detectable, being predominantly associated with proliferative compartments in epithelia. However, non-proliferative populations can also show SC1 immunostaining. No simple relationship between the isoforms identified by immunoblotting of tissue lysates and the tissue immunostaining characteristics was identified. A previously unrecognized species intermediate in mobility between p63 and Np63 was found in several tissues, including nerve and peripheral blood lymphocytes. Interestingly, there is suppression of p63 expression in HaCat cells in a time- and concentration-dependent manner after UV and MMS treatment. Our data provide further information about the complexity of p63 and the SC1 serum will prove to be a useful tool in further studies of this p53 homologue.
Abbreviations: LMS, limb mammary syndrome; PBST, phosphate-buffered saline and 0.1% Tween 20.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Marchini, M. Marabese, E. Marrazzo, P. Mariani, D. Cattaneo, R. Fossati, A. Compagnoni, R. Fruscio, A. A. Lissoni, and M. Broggini {Delta}Np63 expression is associated with poor survival in ovarian cancer Ann. Onc., March 1, 2008; 19(3): 501 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Urist, C. J. Di Como, M.-L. Lu, E. Charytonowicz, D. Verbel, C. P. Crum, T. A. Ince, F. D. McKeon, and C. Cordon-Cardo Loss of p63 Expression Is Associated with Tumor Progression in Bladder Cancer Am. J. Pathol., October 1, 2002; 161(4): 1199 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Di Como, M. J. Urist, I. Babayan, M. Drobnjak, C. V. Hedvat, J. Teruya-Feldstein, K. Pohar, A. Hoos, and C. Cordon-Cardo p63 Expression Profiles in Human Normal and Tumor Tissues Clin. Cancer Res., February 1, 2002; 8(2): 494 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A Hall, A C Woodman, S J Campbell, and N A Shepherd Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein Gut, November 1, 2001; 49(5): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suliman, O. G. Opitz, A. Avadhani, T. C. Burns, W. El-Deiry, D. T. Wong, and A. K. Rustgi p63 Expression Is Associated with p53 Loss in Oral-Esophageal Epithelia of p53-deficient Mice Cancer Res., September 1, 2001; 61(17): 6467 - 6473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain Mol. Cell. Biol., March 1, 2001; 21(5): 1874 - 1887. [Abstract] [Full Text]
|
|